• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三磷酸腺苷结合盒转运体A1(ABCA1)缺乏并不会减弱血脑屏障处人β淀粉样肽(1-40)从脑到血的外流转运。

ATP-binding cassette transporter A1 (ABCA1) deficiency does not attenuate the brain-to-blood efflux transport of human amyloid-beta peptide (1-40) at the blood-brain barrier.

作者信息

Akanuma Shin-ichi, Ohtsuki Sumio, Doi Youko, Tachikawa Masanori, Ito Shingo, Hori Satoko, Asashima Tomoko, Hashimoto Tadafumi, Yamada Kaoru, Ueda Kazumitsu, Iwatsubo Takeshi, Terasaki Tetsuya

机构信息

Division of Membrane Transport and Drug Targeting, Graduate School of Pharmaceutical Sciences, Tohoku University, Aoba, Aramaki, Aoba-ku, Sendai 980-8578, Japan.

出版信息

Neurochem Int. 2008 May;52(6):956-61. doi: 10.1016/j.neuint.2007.12.002. Epub 2007 Dec 8.

DOI:10.1016/j.neuint.2007.12.002
PMID:18201804
Abstract

ATP-binding cassette transporter A1 (ABCA1) mediates apolipoprotein-dependent cholesterol release from cellular membranes. Recent studies using ABCA1 knockout mice have demonstrated that ABCA1 affects amyloid-beta peptide (A beta) levels in the brain and the production of senile plaque. Cerebral A beta(1-40) was eliminated from the brain to the circulating blood via the blood-brain barrier (BBB), which expresses ABCA1. Therefore, in the present study, we examined whether ABCA1 affects the brain-to-blood efflux transport of human A beta(1-40)(hA beta(1-40)) at the BBB. The apparent uptake of [125I]hA beta(1-40) into ABCA1-expressing HEK293 cells was not significantly different from that into parental HEK293 cells. In addition, the apparent uptake was not significantly affected even in the presence of apolipoprotein A-I as a cholesterol release acceptor. Moreover, [125I]hA beta(1-40) elimination from mouse brain across the BBB was not significantly different between ABCA1-deficient and wild-type mice 60 min after its administration into the cerebrum. These results suggest that ABCA1 does not directly transport hA beta(1-40) and a deficiency of ABCA1 does not attenuate the brain-to-blood efflux transport of hA beta(1-40) across the BBB.

摘要

ATP结合盒转运蛋白A1(ABCA1)介导细胞膜上载脂蛋白依赖性胆固醇的释放。最近使用ABCA1基因敲除小鼠的研究表明,ABCA1会影响大脑中β淀粉样肽(Aβ)的水平以及老年斑的形成。大脑中的Aβ(1-40)通过表达ABCA1的血脑屏障(BBB)从大脑清除进入循环血液。因此,在本研究中,我们研究了ABCA1是否会影响血脑屏障处人Aβ(1-40)(hAβ(1-40))从脑到血的外流转运。[125I]hAβ(1-40)在表达ABCA1的HEK293细胞中的表观摄取与在亲本HEK293细胞中的表观摄取没有显著差异。此外,即使存在作为胆固醇释放受体的载脂蛋白A-I时,表观摄取也没有受到显著影响。而且,在将[125I]hAβ(1-40)注入大脑60分钟后,ABCA1缺陷小鼠和野生型小鼠的[125I]hAβ(1-40)通过血脑屏障从脑内清除的情况没有显著差异。这些结果表明,ABCA1不会直接转运hAβ(1-40),并且ABCA1的缺乏不会减弱hAβ(1-40)通过血脑屏障从脑到血的外流转运。

相似文献

1
ATP-binding cassette transporter A1 (ABCA1) deficiency does not attenuate the brain-to-blood efflux transport of human amyloid-beta peptide (1-40) at the blood-brain barrier.三磷酸腺苷结合盒转运体A1(ABCA1)缺乏并不会减弱血脑屏障处人β淀粉样肽(1-40)从脑到血的外流转运。
Neurochem Int. 2008 May;52(6):956-61. doi: 10.1016/j.neuint.2007.12.002. Epub 2007 Dec 8.
2
ABCG2- and ABCG4-mediated efflux of amyloid-β peptide 1-40 at the mouse blood-brain barrier.ABCG2 和 ABCG4 介导的小鼠血脑屏障对淀粉样β肽 1-40 的外排。
J Alzheimers Dis. 2012;30(1):155-66. doi: 10.3233/JAD-2012-112189.
3
Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).阿尔茨海默病小鼠模型(3xTg-AD)中血脑屏障淀粉样β肽流入/流出平衡的年龄依赖性调节
J Alzheimers Dis. 2016;49(2):287-300. doi: 10.3233/JAD-150350.
4
Opposing effects of Apoe/Apoa1 double deletion on amyloid-β pathology and cognitive performance in APP mice.载脂蛋白E/载脂蛋白A1双缺失对APP小鼠淀粉样β蛋白病理及认知能力的相反影响。
Brain. 2015 Dec;138(Pt 12):3699-715. doi: 10.1093/brain/awv293. Epub 2015 Oct 28.
5
Brain pericytes ABCA1 expression mediates cholesterol efflux but not cellular amyloid-β peptide accumulation.脑周细胞 ABCA1 的表达介导胆固醇外流,但不引起细胞淀粉样β肽堆积。
J Alzheimers Dis. 2012;30(3):489-503. doi: 10.3233/JAD-2012-112090.
6
Modulation of Amyloid-β1-40 Transport by ApoA1 and ApoJ Across an in vitro Model of the Blood-Brain Barrier.载脂蛋白 A1 和载脂蛋白 J 对血脑屏障体外模型中淀粉样β1-40 转运的调节作用。
J Alzheimers Dis. 2016 May 25;53(2):677-91. doi: 10.3233/JAD-150976.
7
ABCA7 Downregulation Modifies Cellular Cholesterol Homeostasis and Decreases Amyloid-β Peptide Efflux in an in vitro Model of the Blood-Brain Barrier.ABCA7 下调调节血脑屏障体外模型中的细胞胆固醇稳态并降低淀粉样β肽外排。
J Alzheimers Dis. 2018;64(4):1195-1211. doi: 10.3233/JAD-170883.
8
HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.高密度脂蛋白颗粒大小是 ABCA1 介导的巨噬细胞细胞胆固醇流出的关键决定因素。
Circ Res. 2015 Mar 27;116(7):1133-42. doi: 10.1161/CIRCRESAHA.116.305485. Epub 2015 Jan 14.
9
Oxysterols decrease apical-to-basolateral transport of Aß peptides via an ABCB1-mediated process in an in vitro Blood-brain barrier model constituted of bovine brain capillary endothelial cells.氧化甾醇通过体外血脑屏障模型中牛脑毛细血管内皮细胞的 ABCB1 介导过程降低 Aβ肽的顶侧到基底外侧转运。
Brain Res. 2013 Jun 23;1517:1-15. doi: 10.1016/j.brainres.2013.04.008. Epub 2013 Apr 17.
10
Bexarotene Promotes Cholesterol Efflux and Restricts Apical-to-Basolateral Transport of Amyloid-β Peptides in an In Vitro Model of the Human Blood-Brain Barrier.在人血脑屏障的体外模型中,贝沙罗汀促进胆固醇流出并限制淀粉样β肽从顶端到基底外侧的转运。
J Alzheimers Dis. 2015;48(3):849-62. doi: 10.3233/JAD-150469.

引用本文的文献

1
Memantine/Rosuvastatin Therapy Abrogates Cognitive and Hippocampal Injury in an Experimental Model of Alzheimer's Disease in Rats: Role of TGF-β1/Smad Signaling Pathway and Amyloid-β Clearance.美金刚/瑞舒伐他汀治疗可减轻大鼠阿尔茨海默病实验模型中的认知和海马损伤:转化生长因子-β1/ Smad信号通路及β-淀粉样蛋白清除的作用
J Neuroimmune Pharmacol. 2024 Dec 21;20(1):4. doi: 10.1007/s11481-024-10159-1.
2
The Pathological Effects of Circulating Hydrophobic Bile Acids in Alzheimer's Disease.循环中疏水性胆汁酸在阿尔茨海默病中的病理作用
J Alzheimers Dis Rep. 2023 Mar 6;7(1):173-211. doi: 10.3233/ADR-220071. eCollection 2023.
3
The relationship between amyloid-beta and brain capillary endothelial cells in Alzheimer's disease.
阿尔茨海默病中β淀粉样蛋白与脑毛细血管内皮细胞的关系。
Neural Regen Res. 2022 Nov;17(11):2355-2363. doi: 10.4103/1673-5374.335829.
4
Strategies to gain novel Alzheimer's disease diagnostics and therapeutics using modulators of ABCA transporters.利用ABCA转运蛋白调节剂获取新型阿尔茨海默病诊断方法和治疗手段的策略。
Free Neuropathol. 2021;2:33. doi: 10.17879/freeneuropathology-2021-3528. Epub 2021 Dec 13.
5
Participation of Monocarboxylate Transporter 8, But Not P-Glycoprotein, in Carrier-Mediated Cerebral Elimination of Phenytoin across the Blood-Brain Barrier.单羧酸转运蛋白 8 而非 P-糖蛋白参与了苯妥英经血脑屏障的载体介导脑清除。
Pharm Res. 2021 Jan;38(1):113-125. doi: 10.1007/s11095-021-03003-1. Epub 2021 Feb 1.
6
The Interplay of ABC Transporters in Aβ Translocation and Cholesterol Metabolism: Implicating Their Roles in Alzheimer's Disease.ABC 转运蛋白在 Aβ 易位和胆固醇代谢中的相互作用:暗示它们在阿尔茨海默病中的作用。
Mol Neurobiol. 2021 Apr;58(4):1564-1582. doi: 10.1007/s12035-020-02211-x. Epub 2020 Nov 19.
7
Alteration in the Function and Expression of SLC and ABC Transporters in the Neurovascular Unit in Alzheimer's Disease and the Clinical Significance.阿尔茨海默病神经血管单元中溶质载体(SLC)和ATP结合盒(ABC)转运体的功能及表达改变与临床意义
Aging Dis. 2020 Mar 9;11(2):390-404. doi: 10.14336/AD.2019.0519. eCollection 2020 Apr.
8
Potential microRNA-related targets in clearance pathways of amyloid-β: novel therapeutic approach for the treatment of Alzheimer's disease.淀粉样β蛋白清除途径中潜在的微小RNA相关靶点:治疗阿尔茨海默病的新疗法。
Cell Biosci. 2019 Nov 12;9:91. doi: 10.1186/s13578-019-0354-3. eCollection 2019.
9
Lymphatics in Neurological Disorders: A Neuro-Lympho-Vascular Component of Multiple Sclerosis and Alzheimer's Disease?神经系统疾病中的淋巴管:多发性硬化症和阿尔茨海默病的神经-淋巴-血管组成部分?
Neuron. 2016 Sep 7;91(5):957-973. doi: 10.1016/j.neuron.2016.08.027.
10
Immunohistochemical analysis of transporters related to clearance of amyloid-β peptides through blood-cerebrospinal fluid barrier in human brain.人脑血脑屏障中与β淀粉样肽清除相关转运体的免疫组织化学分析
Histochem Cell Biol. 2015 Dec;144(6):597-611. doi: 10.1007/s00418-015-1366-7. Epub 2015 Oct 8.